Complementary and Alternative Medicine Use in Low-Income African American and Caucasian Adults With Asthma

Asthma Clinical Trial

Official title:

The Role of Complementary and Alternative Medicine (CAM), Folk Care and Faith-Based Approaches in the Home Management of Persistent Asthma in Low-Income African American and Caucasian Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00094419
• Other study ID #: F32AT002012-01
• Status: Completed
• Phase: N/A
• First received: October 18, 2004
• Last updated: August 11, 2008
• Start date: November 2004
• Est. completion date: June 2006

Study information

• Verified date: August 2008
• Source: National Center for Complementary and Integrative Health (NCCIH)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to identify the types of and frequency of use of complementary and alternative medicine (CAM) strategies among low-income Caucasian and African American adults with persistent asthma. The overall goal is to collect data that will increase understanding of health beliefs and behaviors in people with low-income backgrounds so that studies can be created that may help modify and improve patients' symptoms of asthma.

Description:

The rates of asthma-related deaths and disease are disproportionately high among African Americans compared to Caucasians. Surveys indicate that middle- and upper-income Caucasians use more CAM than African Americans, but the therapies utilized are different. This study will determine how well people with persistent asthma adhere to their treatment and whether the type and frequency of use of CAM affects treatment adherence.

Participants will begin this study by taking part in an interview about adherence to their current inhaled corticosteroids (ICS) regimen and their personal CAM use. After completing the interview, participant adherence to their ICS regimen will be monitored for 6 weeks. Depending on the type of ICS participants are taking, monitoring will be conducted either by participant self-reporting or electronic monitors that record the time and date of medication inhalation. Participant adherence will also be assessed at study completion.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: June 2006
• Est. primary completion date: June 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 21 Years to 50 Years

Eligibility

Inclusion Criteria:

• Physician-diagnosed asthma with episodes that last for long periods of time

• Medicaid recipients

• Self-identify as African American or Caucasian

• Daily use of inhaled corticosteroids

• Able to speak English

• Have mental capacity to understand and participate in the study

Exclusion Criteria:

• Prisoners

• History of smoking at least ten packs of cigarettes per year

• Currently smoke more than one and a half packs of cigarettes per week

Study Design

N/A

Related Conditions & MeSH terms

• Asthma

Locations

Country	Name	City	State
United States	Johns Hopkins Bayview Campus	Baltimore	Maryland
United States	Presbyterian Medical Center at the University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

United States,